Keros Therapeutics
KROS
KROS
103 hedge funds and large institutions have $433M invested in Keros Therapeutics in 2022 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 20 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
103
Holders Change
-2
Holders Change %
-1.9%
% of All Funds
1.74%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
20
Increased
43
Reduced
20
Closed
21
Calls
$1.84M
Puts
–
Net Calls
+$1.84M
Net Calls Change
-$3.83M
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$99.5M |
| 2 |
2
Citigroup
New York
|
$12.8M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$27.4M |
| 4 |
4
Alkeon Capital Management
New York
|
$32.5M |
| 5 |
5
Renaissance Technologies
New York
|
$3.92M |
